208 related articles for article (PubMed ID: 14677356)
1. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
Martín-Crespo R; Luque R
Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
[TBL] [Abstract][Full Text] [Related]
2. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
[TBL] [Abstract][Full Text] [Related]
4. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood.
Yucel S; Kutlu O; Kukul E; Baykara M
Urology; 2004 Nov; 64(5):1020-5; discussion 1025. PubMed ID: 15533498
[TBL] [Abstract][Full Text] [Related]
5. [Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
Rodríguez do Forno A; Ariceta Iraola G
An Esp Pediatr; 2001 Jan; 54(1):38-43. PubMed ID: 11181193
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
[TBL] [Abstract][Full Text] [Related]
8. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
9. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
[TBL] [Abstract][Full Text] [Related]
10. Oxybutynin, desmopressin and enuresis.
Nevéus T
J Urol; 2001 Dec; 166(6):2459-62. PubMed ID: 11696812
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis.
Leebeek-Groenewegen A; Blom J; Sukhai R; Van Der Heijden B
J Urol; 2001 Dec; 166(6):2456-8. PubMed ID: 11696811
[TBL] [Abstract][Full Text] [Related]
12. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
Derman O; Kanbur NO; Kinik E
Int J Adolesc Med Health; 2004; 16(4):377-85. PubMed ID: 15712975
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
15. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
[TBL] [Abstract][Full Text] [Related]
16. New treatment protocol for primary nocturnal enuresis in children according to ultrasound bladder measurements.
Azhir A; Gheissari A; Fragzadegan Z; Adebi A
Saudi Med J; 2008 Oct; 29(10):1475-9. PubMed ID: 18946576
[TBL] [Abstract][Full Text] [Related]
17. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
De Grazia E; Cimador M
Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
[TBL] [Abstract][Full Text] [Related]
18. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
[TBL] [Abstract][Full Text] [Related]
19. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
20. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
